We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Electrical Changes Predict Heart Failure

By HospiMedica staff writers
Posted on 23 Mar 2005
A new study has shown that electrical changes in the heart, long before a patient shows any clinical symptoms, can spur a later phase of changes that lead to heart failure caused by arrhythmias.

Scientists isolated small samples of heart tissue about the size of large postage stamps from dogs in various stages of heart failure. More...
Using a technique called optical mapping, they stained the tissue samples with voltage- or calcium-sensitive dyes and excited the photosensitive dyes by shining a green light on them. The dyes emitted light in different amounts, depending on the cellular voltage or calcium levels in the individual tissue samples. The emitted light was collected by a sensitive optical detection system, converted to current, and stored on a computer for analysis.

The researchers demonstrated that electrical disturbances occurred in two distinct phases relative to mechanical abnormalities. The early changes involved a delay in the timing of electrical recovery of heart muscle following each beat, whereas the later changes involved the loss of electrical synchrony among various regions of the heart. The early changes likely contributed to mechanical abnormalities that led to the later changes. Both the early and late changes in electrical properties were necessary to cause a lethal arrhythmia. The researchers estimate that up to 50% of deaths in patients with heart failure are unexpected and sudden, and are the result of lethal arrhythmias.

"By the time most patients are diagnosed with heart failure, it's too late to really improve their condition,” said Fadi G. Akar, Ph.D., a research assistant professor at the Johns Hopkins School of Medicine (Baltimore, MD, USA). "By defining the early electrical changes, we hope to identify new targets for therapy that can either reverse or, at the very least, hinder the progression of the vicious cycle of events that ultimately leads to death.”

Nearly five million people suffer from heart failure in the United States alone every year and more than 250,000 die annually from the condition. The incidence and prevalence of heart failure continue to increase with the aging of the population.




Related Links:
Johns Hopkins

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.